Venous thrombosis and cancer. Evaluation of venous thromboembolism risk factors;Thromboses veineuses des membres inferieurs et cancer. Evaluation des facteurs de risque de thrombose veineuse en milieu medical

Journal des Maladies Vasculaires

Volumn 22, Issue 4, 1997, Pages 234-238

  Giauffret, F ^a   Pottier, P ^b   Pistorius, M A ^b   Planchon, B ^b  

^a CHU RANGUEIL   (France)

^b HÔTEL DIEU   (France)

Author keywords

Cancer; Risk factors; Venous thrombosis

Indexed keywords

ADULT; AGED; ANTICOAGULATION; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CHRONIC DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERCOAGULABILITY; MALE; PROGNOSIS; RISK FACTOR; SURVIVAL; THROMBOEMBOLISM; VEIN THROMBOSIS; CLINICAL TRIAL; EVALUATION; INCIDENCE; MIDDLE AGED; NEOPLASM; PROSPECTIVE STUDY; THROMBOPHLEBITIS;

AGED; AGED, 80 AND OVER; EVALUATION STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHLEBITIS;

EID: 0031253389     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. BELL WR, STARKSEN NF, PORTEFIELD JK. - Trousseau's syndrome : devastating coagulopathy in the absence of heparin. Am J Med 1985 ; 79 : 423-30.
2. BERGMANN JF. - Prévention de la thrombose veineuse en milieu médical : plaidoyer pour des essais cliniques qui font cruellement défaut. Sang, Thrombose, Vaisseaux 1995 ; 7 : 655-7.
3. DEBOURDEAU P, MEYER G, SAYEG H, MARJANOVIC Z, BASTIT L, CABANE J, MERRER J, EXTRA JM, FARGE D. - Traitement anticoagulant classique de la maladie thromboembolique veineuse chez les patients cancéreux. A propos d'une série rétrospective de 71 patients. Rev Med Interne 1996 ; 17 : 207-12.
4. DOLL DC, YARBRO JW. - Vascular toxicity associated with antineoplastic agents. Seminars in Oncology 1992 ; 19 : 580-96.
5. LEIZOROVICZ, A, HAUGH MC, CHAPUIS FR, SAMAMA MM, BOISSEL JP. - Low molecular weight heparin in prevention of perioperative thrombosis. Br Med J 1992 ; 305 : 913-20.
6. LEVINE MN, GENT M, HIRSH J et al. - The thrombogenic effect of anticancer drug therapy in women stage II breast cancer. N Engl J Med 1988; 3 : 404-7.
7. LEVINE M, HIRSH J, GENT M, ARNOLD A, WARR D, FALANGA A et al. - Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 1994 : 343 : 886-9.
8. MEYER G, FARGE D, SAUVAGET F, DIEHL JL, HERVE R, ROUFFY J, SORS H et al. - Maladie Thrombo-embolique et Cancer. Presse Méd 1994 ; 23 : 1767-71.
9. MINNA JD, BUNN PA Jr. - Paraneoplastic syndromes. In : « De Vita VT Jr, Hellman S, Rosenberg SA, ed. Cancer: principles and practice of oncology. 3rd ed. » Philadelphia: JB Lippincott, 1989; 1920-40.
10. COUTURAUD F, LEROYER C, LE MOIGNE E, OGER E, MOTTIER D. - Prévention de la thrombose veineuse profonde en milieu médical. Presse Med 1996 ; 25 : 1935-40.
11. PISTORIUS MA, LE MENNER G, PLANCHON B. - Thromboses veineuses profondes et cancer. Evaluation à un an du bilan étiologique des patients hospitalisés en Médecine Interne. J Mal Vasc 1994; 19 : 273-7.
12. RAHR HB, SORENSEN JV. - Venous thromboembolism and cancer. Blood Coag Fibrinol 1992 ; 3 : 451-60.
13. RICKLES FR, EDWARDS RL. - Activation of blood coagulation in cancer : Trousseau's syndrom revisited. Blood 1983 ; 62 : 14-31.
14. SACK GH Jr, LEVIN J, BELL WR. - Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms : clinical, pathophysiologic, and therapeutic features. Medicine 1977 ; 56 : 1-37.
15. THROMBOEMBOLIC RISK FACTORS (THRIFT) CONSENSUS GROUP. - Risk and prophylaxis for venous thromboembolism in hospital patients. Br Med J 1992 ; 305 : 567-74.
16. TROUSSEAU A. - Phlegmatia alba dolens. Clin Med Hôtel-Dieu Paris, 1885 ; 3 : 695-739.
17. ZACHARSKI LR, MEMOLI VA, COSTANTINI V, WOJTUKIEWICZ MZ. - Cloning factors in tumor tissue : implications for cancer therapy. Blood Coag Fibrinol 1990 ; 1 : 71-8.